ArticleJournal of clinical and experimental hepatology

Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study).

Satender P Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.